RCAR News and Press, Renovacare Inc From 02/03/22

RM LAW Announces Investigation of RenovaCare, Inc. PR Newswire BERWYN, Pa. , Feb. 3, 2022 /PRNewswire/ -- RM LAW, P.C. is investigating potential claims against the board of directors of RenovaCare, Inc. (OTC: RCAR) investors concerning ...

SCOTTSDALE, Ariz., Oct. 14, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), developer of patented cell therapy technologies for the regeneration of skin and tissues, today announced the award of a new SkinGun™ patent by the United States Patent a...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RenovaCare To Contact Him Directly To Discuss Their Options NEW YORK - ( NewMediaWire ) - September 12, 2021 - Faruqi & Faruqi, LLP, a leading national securities law firm, is...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RenovaCare To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - August 27, 2021) -  Faruqi & Faruqi, LLP, a leading national securities la...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RenovaCare To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - August 8, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm,...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RenovaCare To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - August 4, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm,...

ROSELAND, N.J., July 22, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), developer of patented technologies for the regeneration of skin and other organs and tissues, today provided an update on its clinical trial evaluating the safety and feasibility o...

ROSELAND, N.J., June 07, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced that it is initiating a clinical trial at four burn centers in the United States. This follows the Company’s recent Investigational Device Exemption (IDE) ap...

ROSELAND, N.J., June 01, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ) today announced that it intends to vigorously defend itself and its stockholders against allegations made by the U.S. Securities and Exchange Commission (“SEC”) in a c...

ROSELAND, N.J., May 06, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), today announced that its Investigational Device Exemption (IDE) application has been granted full approval by the U.S. Food and Drug Administration (FDA). This approval enables Reno...